321 related articles for article (PubMed ID: 16123920)
1. Contrast-enhanced sonography for the characterisation of hepatocellular carcinomas--correlation with histological differentiation.
Strobel D; Kleinecke C; Hänsler J; Frieser M; Händl T; Hahn EG; Bernatik T
Ultraschall Med; 2005 Aug; 26(4):270-6. PubMed ID: 16123920
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma.
Takahashi M; Maruyama H; Ishibashi H; Yoshikawa M; Yokosuka O
AJR Am J Roentgenol; 2011 Feb; 196(2):W123-31. PubMed ID: 21257852
[TBL] [Abstract][Full Text] [Related]
3. Correlation between SonoVue enhancement in CEUS, HCC differentiation and HCC diameter: analysis of 130 patients with hepatocellular carcinoma (HCC).
von Herbay A; Vogt C; Westendorff J; Häussinger D; Gregor M
Ultraschall Med; 2009 Dec; 30(6):544-50. PubMed ID: 19998208
[TBL] [Abstract][Full Text] [Related]
4. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
[TBL] [Abstract][Full Text] [Related]
5. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of primary malignancies of the liver using contrast-enhanced sonography: correlation with pathology.
Fan ZH; Chen MH; Dai Y; Wang YB; Yan K; Wu W; Yang W; Yin SS
AJR Am J Roentgenol; 2006 Jun; 186(6):1512-9. PubMed ID: 16714638
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation.
Nicolau C; Catalá V; Vilana R; Gilabert R; Bianchi L; Solé M; Pagés M; Brú C
Eur Radiol; 2004 Jun; 14(6):1092-9. PubMed ID: 15007620
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced, wide-band, phase inversion harmonic power Doppler imaging of hepatocellular carcinoma.
Janica J; Serwatka W; Polaków J; Kordecki K; Łebkowska U; Walecki J; Dobrzycki S
Med Sci Monit; 2004 Jun; 10 Suppl 3():32-5. PubMed ID: 16538196
[TBL] [Abstract][Full Text] [Related]
9. Vascularization of liver tumors - preliminary results with Coded Harmonic Angio (CHA), phase inversion imaging, 3D power Doppler and contrast medium-enhanced B-flow with second generation contrast agent (Optison).
Jung EM; Kubale R; Jungius KP; Jung W; Lenhart M; Clevert DA
Clin Hemorheol Microcirc; 2006; 34(4):483-97. PubMed ID: 16687788
[TBL] [Abstract][Full Text] [Related]
10. Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma.
Arita J; Hasegawa K; Takahashi M; Hata S; Shindoh J; Sugawara Y; Kokudo N
AJR Am J Roentgenol; 2011 Jun; 196(6):1314-21. PubMed ID: 21606294
[TBL] [Abstract][Full Text] [Related]
11. Contrast-enhanced sonography in the characterization of small hepatocellular carcinomas in cirrhotic patients: comparison with contrast-enhanced ultrafast magnetic resonance imaging.
Giorgio A; De Stefano G; Coppola C; Ferraioli G; Esposito V; Di Sarno A; Giorgio V; De Stefano M; Sangiovanni V; Liorre G; Del Viscovo L
Anticancer Res; 2007; 27(6C):4263-9. PubMed ID: 18214030
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT.
Meloni MF; Goldberg SN; Livraghi T; Calliada F; Ricci P; Rossi M; Pallavicini D; Campani R
AJR Am J Roentgenol; 2001 Aug; 177(2):375-80. PubMed ID: 11461867
[TBL] [Abstract][Full Text] [Related]
13. Small hepatocellular carcinomas in cirrhosis: differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging.
Hayashida M; Ito K; Fujita T; Shimizu A; Sasaki K; Tanabe M; Matsunaga N
Magn Reson Imaging; 2008 Jan; 26(1):65-71. PubMed ID: 17566685
[TBL] [Abstract][Full Text] [Related]
14. [Early diagnosis of small hepatocellular carcinoma by new contrast-enhanced ultrasound technique].
Chen MH; Dai Y; Yan K; Fan ZH; Wu W; Wang YB; Yin SS; Yang W; Li JY
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Oct; 37(5):458-62. PubMed ID: 16224512
[TBL] [Abstract][Full Text] [Related]
15. Value of liver parenchymal phase contrast-enhanced sonography to diagnose premalignant and borderline lesions and overt hepatocellular carcinoma.
Inoue T; Kudo M; Maenishi O; Komuta M; Nakashima O; Kojiro M; Maekawa K
AJR Am J Roentgenol; 2009 Mar; 192(3):698-705. PubMed ID: 19234266
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of contrast-enhanced ultrasound washout rate in predicting hepatocellular carcinoma differentiation.
Feng Y; Qin XC; Luo Y; Li YZ; Zhou X
Ultrasound Med Biol; 2015 Jun; 41(6):1553-60. PubMed ID: 25747937
[TBL] [Abstract][Full Text] [Related]
17. Depiction of portal supply in early hepatocellular carcinoma and dysplastic nodule: value of pure arterial ultrasound imaging in hepatocellular carcinoma.
Kudo M; Hatanaka K; Inoue T; Maekawa K
Oncology; 2010 Jul; 78 Suppl 1():60-7. PubMed ID: 20616586
[TBL] [Abstract][Full Text] [Related]
18. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
19. Characterization and detection of hepatocellular carcinoma (HCC): comparison of the ultrasound contrast agents SonoVue (BR 1) and Levovist (SH U 508A)--comparison of SonoVue and Levovist in HCC.
von Herbay A; Haeussinger D; Gregor M; Vogt C
Ultraschall Med; 2007 Apr; 28(2):168-75. PubMed ID: 17447216
[TBL] [Abstract][Full Text] [Related]
20. Sonographic characterisation of hepatocellular carcinoma at time of diagnosis.
Ignee A; Weiper D; Schuessler G; Teuber G; Faust D; Dietrich CF
Z Gastroenterol; 2005 Mar; 43(3):289-94. PubMed ID: 15765302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
